AMentoria Raises R$1M Seed to Expand Medicine Admissions Platform in Brazil

AMentoria Closes Seed Round

AMentoria Educacao, a Brazilian edtech focused on university entrance exam preparation, has raised R$1 million in seed funding. The round was announced on September 21, 2026, and was led by Triaxis Capital. Additional investors include Insper Angels, Crescera Capital, Anjos do Brasil, WOW Aceleradora, Cristiano Fae, and Adriano Silveira.

What AMentoria Does

Founded in 2019 in Natal, AMentoria prepares students for the ENEM exam and competitive university entrance processes, with a particular focus on medicine admissions. The platform individualizes study plans based on performance metrics and weekly simulations, pairing each student with a mentor who has been admitted to a medicine program.

The company serves students directly and also partners with schools through a B2B2C model, giving it two routes to market: direct-to-student acquisition and institutional distribution through school partnerships.

Traction

AMentoria reports more than 1,000 medicine admissions and over 40,000 one-on-one mentoring sessions. Those figures point to a track record in one of Brazil's most competitive educational segments, where admission to a medicine program typically requires top-tier ENEM scores and intensive preparation.

The mentor-matching model differentiates AMentoria from generic test-prep platforms. By connecting students with mentors who have already navigated medicine admissions, the company combines content, analytics, and human coaching — a blend that tends to drive higher engagement and retention than self-serve study tools alone.

Why This Round Matters

The seed round gives AMentoria capital to expand its platform and reach at a time when Brazilian edtech continues to attract investor interest, particularly in high-stakes exam preparation. The investor group includes angel networks, accelerators, and venture funds, suggesting a mix of strategic guidance and growth capital.

For acquisition watchers, AMentoria is a potential target for larger education companies, school networks, or edtech consolidators looking to add a medicine-admissions specialty and a B2B2C channel into private and public schools. Its mentoring network and admissions outcomes data could be difficult to replicate quickly.

What to Watch

• How AMentoria uses the seed funding: technology, mentor recruitment, or school partnerships.
• Expansion beyond medicine into other competitive university courses.
• Growth of the B2B2C model with schools as a distribution channel.

The round was led by Triaxis Capital, with participation from Insper Angels, Crescera Capital, Anjos do Brasil, WOW Aceleradora, Cristiano Fae, and Adriano Silveira. The funding date is September 21, 2026.